New Proposed Regulations for Medicare Advantage Modernization
Discover the new CMS proposed regulations for Medicare Advantage and Part D aimed at modernization by 2027, impacting quality measures and beneficiary protections.
Discover the new CMS proposed regulations for Medicare Advantage and Part D aimed at modernization by 2027, impacting quality measures and beneficiary protections.
CMS 2027 Proposed Rule aims to modernize Medicare Advantage and Part D programs with updates to quality metrics, risk adjustment models, and beneficiary protections. Key changes include Star Ratings revisions, incorporation of Inflation Reduction Act drug pricing provisions, and requests for stakeholder feedback on quality bonus payments and care coordination.
CMS issues proposed 2027 rules updating Medicare Advantage and Part D programs, implementing Inflation Reduction Act changes, revising star ratings, marketing oversight, and program integrity requirements.
CMS's 2027 Proposed Rule introduces major Medicare Advantage and Part D program reforms including Star Ratings revisions, risk adjustment data access expansion, marketing rules relaxation, and new special enrollment periods for provider terminations.
CMS requests public comments on 2027 proposed regulatory changes to Medicare Advantage, Part D, and Cost Plan programs to streamline compliance and reduce administrative burdens.
Navigate 2026 Medicare open enrollment with expert insights on plan comparison, cost management, and avoiding common enrollment mistakes for better healthcare coverage.
CMS's 2027 proposed rule outlines key Medicare Advantage and Part D program updates, codifying Inflation Reduction Act changes, adjusting Star Ratings, and modernizing marketing and risk adjustment frameworks.
CMS releases proposed rule for CY2027 Medicare Advantage and Part D programs with key changes to Part D redesign, Star Ratings, special enrollments, and marketing compliance. Regulatory updates impact plan operations, quality metrics, and data access.
CMS proposes extensive changes to the 2027 Medicare Advantage and Part D programs, including benefit design reforms, new enrollment rules, marketing policy updates, and modifications to quality ratings and special needs plans.
Medicare Part D faces significant plan reductions and rising costs in 2026. Beneficiaries must review their drug plans before the December 7 deadline to avoid premium hikes and coverage losses.